Skip to main content

Increased COVID Hospitalization Numbers May Not Tell Full Story, When to Get a COVID Test, How to Treat Your Results, and Don’t Try to Get COVID On Purpose

January 13, 2022

During the week of January 7 – January 13, infectious disease experts from the Department of Medicine were featured in the following news stories. If you caught Covid-19 over the holidays, here’s what you need to know – Dr. David Wohl (CNN) Coronavirus omicron updates: Here’s what to know in North Carolina on Jan. 7 – Dr. David … Read more

‘Silver Lining’ of Omicron: More Hospital Patients But Fewer in Intensive Care, and Other COVID News Featuring Infectious Diseases Experts the Week of December 31 – January 6.

January 10, 2022

The following clickable headlines link directly to outside media outlets, which feature UNC Department of Medicine faculty during the week of December 31, 2021 – January 6, 2022.  The ‘silver lining’ of omicron: More hospital patients but fewer in intensive care – Dr. David Wohl (The News & Observer) Health experts stress the best protection depends … Read more

Crockett Study Considers Value of Endoscopic Clipping After Resection in Large Serrated Polyps

January 9, 2022

Among patients with large serrated polyps, the risk for bleeding after endoscopic mucosal resection was low, with no significant benefit seen with resection clipping, according to a study. “[This] study suggests that endoscopic clipping is not necessary to prevent post-polypectomy bleeding after [endoscopic mucosal resection] of large serrated polyps,” Seth D. Crockett, MD, MPH, associate … Read more

Increasing Participation of Underrepresented in Lupus Clinical Trials

January 9, 2022

Saira Sheikh, MD, the Linda Coley Sewell Distinguished Professor of Medicine in the division of rheumatology, and research associate Tessa Englund, PhD, MPH, described the barriers in lupus clinical trial enrollment and how they can be addressed to ensure equitable representation. Read the article published in Rheumatology Advisor.  

Cavender Discusses Study Showing Cangrelor Reduces Ischemic Events Versus Clopidogrel Early After PCI

December 31, 2021

Treatment with the IV P2Y12 inhibitor cangrelor reduced the number of early ischemic events after PCI, primarily MI and stent thrombosis, compared with oral clopidogrel, according to the results of the CHAMPION PHOENIX trial. “Patients undergoing PCI are at risk of activation of the clotting process, formation of intravascular thrombus and subsequent myocardial infarction,” said Matthew … Read more

NC Shatters Record High COVID-19 Daily Positivity Rate, Tweens Have the Highest Case Rate, a New Drug to Prevent COVID, and What to Know As Omicron Spreads

December 31, 2021

Faculty from the division of infectious diseases were featured in the following COVID news stories the week of December 24 – December 30. NC shatters record high COVID-19 daily positivity rate in first metric update since holiday weekend – Dr. David Wohl (ABC11) Tweens, 10-14, have highest COVID case rate in the state – Dr. David Wohl … Read more